GlucotrackGCTK
13F holders, Q2 2025 (June 30)10holders
$6.00avg. 13F price*
At the end of Q2 2025, 10 institutions reported holding Glucotrack Inc. (GCTK) in their 13F filings. The largest holders were Bank of America Corp. ($25K), Tower Research Capital LLC (TRC) ($11K) and Barclays PLC ($5K).
- Company
- Glucotrack Inc.
- CUSIP
- 45824Q804
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $15K |
| Exits | 0 | $0 |
Ownership 10 holders
| Bank of America Corp. | 0.00% | Add +102125.0% | 4,089 | $25K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 1,772 | $11K |
| Barclays PLC | 0.00% | New | 751 | $5K |
| NFSG Corp | 0.00% | New | 34 | $204 |
| FMR LLC | 0.00% | New | 21 | $128 |
| SBI Securities Co., Ltd. | 0.00% | Reduce -44.4% | 10 | $60 |
| Morgan Stanley | 0.00% | Reduce -96.0% | 1 | $6 |
| Northwestern Mutual Wealth Management Co. | 0.00% | New | 1 | $6 |
| UBS Group AG | 0.00% | No change | 1 | $6 |
| Osaic Holdings, Inc. | 0.00% | No change | 1 | $6 |
"% of holder's portfolio" is GCTK's weight in each manager's 13F, not the share of Glucotrack Inc. the manager owns.